Researchers at the University of Hull in the UK have identified a family of proteins that could potentially be used as biomarkers to predict resistance to chemotherapy in estrogen receptor-positive (ER-positive) breast cancer patients. In an "in press" issue of their study published online in the Journal of Proteomics on 3 April, lead researcher Dr Lynn Cawkwell and colleagues explain how they discovered a number of potential biomarkers for resistance to epirubicin, docetaxel and other chemo drugs...
More...
More...